Facilitated By

San Antonio Medical Foundation

A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL EXAMINING THE SAFETY AND EFFICACY OF MIDAZOLAM INTRANASAL SPRAY (USL261) FOR THE TREATMENT OF INTERMITTENT BOUTS OF INCREASED SEIZURE ACTIVITY IN THE EPILEPSY MONITORING UNIT (EMU)

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Morgan,Lola
Funded by
UPSHER-SMITH LABORATORIES
Research Start Date
Status
Inactive
Clinical Care
Drug Discovery
Neuroscience